Glyphic Biotechnologies, Inc. — Form D
Glyphic Biotechnologies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-16. The offering totals $52.9M, of which $33.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-16
- Form: D
- Accession: 0002011516-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $52.9M
- Amount sold: $33.2M
- Remaining: $19.7M
- Investors: 37
- Date of first sale: 2024-02-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505449
Issuer
- Name: Glyphic Biotechnologies, Inc.
- CIK: 0002011516
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 169 MADISON AVENUE, NEW YORK, NY, 10016
- Phone: 619-944-9009
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Craig Asher | Director | Santa Cruz, CA |
| Daniel Estandian | Director | New York, NY |
| Joshua Yang | Director | New York, NY |
| Jimmy Yun | Director | New York, NY |
| Daniel Estandian | Executive Officer | New York, NY |
| Joshua Yang | Executive Officer | New York, NY |
More